Pronova BioPharma ASA (OSL:PRON) Pronova BioPharma Announces Strategic Supply Agreement For A Fixed Dose Combination Product With Omacor And Simvastatin
Pronova BioPharma ASA (OSL:PRON) 5 November 2008, Lysaker, Norway: Pronova BioPharma ASA (OSE: PRON.OL) ("Pronova BioPharma" or the "company") today announces that its subsidiary Pronova BioPharma Norge AS has entered into a strategic supply agreement with Defiante Farmacêutica SA, a subsidiary of the Italian sigma-tau group, for the exclusive supply of the active pharmaceutical ingredient (API) for a fixed dose combination product with Omacor and simvastatin in Spain, France and Portugal, with a possibility to add other countries upon prior written agreement.